Energy shares lead Wall Street to worst day since
early October
NEW
YORK Mon Jan 5, 2015 5:18pm EST
(Reuters) - The S&P 500 had its worst day in almost three
months on Monday, with energy shares leading the decline as global economic
concerns were compounded by swooning oil prices.
The S&P closed
off 1.8 percent in its first four-day losing streak since December 2013 and its
biggest drop since Oct. 9. It fell as much as 1.99 percent in the session while
the Dow Jones Industrial Average tumbled as much as 2 percent.
Crude oil futures
prices dropped to their lowest since 2009 amid a global supply glut and
lackluster demand. U.S. crude CLc1 fell 5 percent to below $50 a
barrel.
The euro fell to a near nine-year low
against the dollar of $1.18605 on the EBS platform, tumbling on political
uncertainty in Greece and
fears of a possible Greek exit from the euro
zone.
The Greece question
was front and center for Paul Nolte, portfolio manager at Kingsview Asset
Management.
"What
you've done is thrown that entire area up for grabs, it will be very hard to
see much in the way of economic growth if Greece has to go back to their currency," he said.
"It would create a lot more chaos and take everybody's focus away from
economic growth."
There
were more than three times as many declining stocks on the New York Stock
Exchange as advancing issues and more than twice as many Nasdaq losers than gainers.
Strength
in the dollar also put more pressure on dollar-denominated commodities. A measure of the greenback against a
basket of major currencies .DXY hit its highest since December 2005.
The Dow Jones industrial average .DJI fell 331.34 points, or 1.86 percent, to
17,501.65, theS&P 500 .SPX lost 37.62 points, or 1.83 percent, to
2,020.58 and the Nasdaq Composite.IXIC dropped 74.24 points, or 1.57 percent,
to 4,652.57.
The S&P 500 energy
sector .SPNY closed off 4 percent, its largest daily percentage decline since
November 28. It fell almost 20 percent in the second half of last year.
The
health sector .SPXHC, the S&P's best performer on Monday, still fell 0.6
percent. Medical device maker Boston Scientific (BSX.N) was the
S&P's biggest winner with a 4 pct gain after a brokerage upgrade.
Another
bright spot was Gilead Sciences Inc (GILD.O) whose shares
rose percent after CVS Health Corp (CVS.N), one of the
largest U.S. managers of drug benefits, said it will give Gilead's hepatitis C
treatment preferred status and cover competitor AbbVie Inc's (ABBV.N) treatment
only as an exception. AbbVie shares lost 2 percent.
Declining
issues outnumbered advancing ones on the NYSE by 2,413 to 714, for a 3.38-to-1
ratio on the downside; on the Nasdaq, 1,961 issues
fell and 801 advanced for a 2.45-to-1 ratio favoring decliners.
The
benchmark S&P 500 index was posting 6 new 52-week highs and 6 new
lows; theNasdaq Composite was
recording 54 new highs and 44 new lows.
About 7.09 billion shares traded on
U.S. exchanges, above the 6.87 billion December average, according to data from
BATS Global Markets.
No comments:
Post a Comment